Participants in this research study have tumors that express somatostatin receptors such as
neuroendocrine tumors, medulloblastoma, meningioma, and neuroblastoma.
Approximately 64 people will participate in this study conducted at the University of Iowa.
Phase:
Phase 2
Details
Lead Sponsor:
Sue O'Dorisio University of Iowa
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH)
Treatments:
Amino-acid, glucose, and electrolyte solution Edotreotide Octreotide Radiopharmaceuticals Somatostatin